Addus HomeCare (ADUS) to Release Quarterly Earnings on Monday

Addus HomeCare (NASDAQ:ADUS - Get Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, May 6th. Analysts expect the company to announce earnings of $0.97 per share for the quarter. Parties interested in listening to the company's conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, February 26th. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The firm had revenue of $276.35 million during the quarter, compared to analyst estimates of $274.02 million. On average, analysts expect Addus HomeCare to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Stock Down 0.4 %

NASDAQ:ADUS traded down $0.36 during mid-day trading on Monday, hitting $94.18. 146,739 shares of the company's stock traded hands, compared to its average volume of 121,479. The company has a fifty day moving average of $97.69 and a 200 day moving average of $91.79. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. Addus HomeCare has a twelve month low of $77.30 and a twelve month high of $104.61. The company has a market capitalization of $1.54 billion, a P/E ratio of 24.53, a P/E/G ratio of 1.86 and a beta of 0.95.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ADUS. Barclays cut Addus HomeCare from an "equal weight" rating to an "underweight" rating and set a $83.00 price target for the company. in a research report on Tuesday, April 23rd. Royal Bank of Canada reissued an "outperform" rating and set a $102.00 target price on shares of Addus HomeCare in a report on Thursday, February 29th. Oppenheimer reaffirmed an "outperform" rating and issued a $118.00 price target on shares of Addus HomeCare in a report on Tuesday, March 26th. Finally, William Blair reiterated an "outperform" rating on shares of Addus HomeCare in a research note on Monday, February 5th. One investment analyst has rated the stock with a sell rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $103.00.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.